1. Home
  2. CYTK vs CAMT Comparison

CYTK vs CAMT Comparison

Compare CYTK & CAMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • CAMT
  • Stock Information
  • Founded
  • CYTK 1997
  • CAMT 1987
  • Country
  • CYTK United States
  • CAMT Israel
  • Employees
  • CYTK N/A
  • CAMT N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • CAMT Electronic Components
  • Sector
  • CYTK Health Care
  • CAMT Technology
  • Exchange
  • CYTK Nasdaq
  • CAMT Nasdaq
  • Market Cap
  • CYTK 4.6B
  • CAMT 3.8B
  • IPO Year
  • CYTK 2004
  • CAMT 2000
  • Fundamental
  • Price
  • CYTK $58.45
  • CAMT $120.59
  • Analyst Decision
  • CYTK Buy
  • CAMT Strong Buy
  • Analyst Count
  • CYTK 16
  • CAMT 11
  • Target Price
  • CYTK $76.73
  • CAMT $108.00
  • AVG Volume (30 Days)
  • CYTK 2.0M
  • CAMT 570.0K
  • Earning Date
  • CYTK 11-05-2025
  • CAMT 11-11-2025
  • Dividend Yield
  • CYTK N/A
  • CAMT 1.10%
  • EPS Growth
  • CYTK N/A
  • CAMT 38.64
  • EPS
  • CYTK N/A
  • CAMT 2.73
  • Revenue
  • CYTK $85,738,000.00
  • CAMT $471,588,000.00
  • Revenue This Year
  • CYTK $363.61
  • CAMT $17.22
  • Revenue Next Year
  • CYTK $64.08
  • CAMT $8.35
  • P/E Ratio
  • CYTK N/A
  • CAMT $44.19
  • Revenue Growth
  • CYTK 2635.74
  • CAMT 27.88
  • 52 Week Low
  • CYTK $29.31
  • CAMT $47.41
  • 52 Week High
  • CYTK $63.86
  • CAMT $127.08
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 60.20
  • CAMT 63.42
  • Support Level
  • CYTK $58.84
  • CAMT $109.51
  • Resistance Level
  • CYTK $63.86
  • CAMT $127.08
  • Average True Range (ATR)
  • CYTK 2.52
  • CAMT 5.56
  • MACD
  • CYTK -0.26
  • CAMT 0.32
  • Stochastic Oscillator
  • CYTK 47.43
  • CAMT 74.03

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About CAMT Camtek Ltd.

Camtek Ltd is engaged in the manufacturing of metrology and inspection equipment and software solutions for the semiconductor industry. Its systems inspect wafers for various semiconductor market segments, including Advanced Packaging, Heterogenous Integration (HI), Compound Semiconductors, Memory, and foundries among others. Geographically, it derives maximum revenue from China followed by Asia Pacific, Korea, United States, and Europe. The company's products and services include Surface Inspection, Bump Inspection and Metrology, and others.

Share on Social Networks: